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bstract
Dietary restriction (DR) extends lifespan in diverse organisms and, in animal and cellular models, can delay a range of aging-related 
iseases including Alzheimer’s disease (AD). A better understanding of the mechanisms mediating these interactions, however, may reveal 
ovel pathways involved in AD pathogenesis, and potential targets for disease-modifying treatments and biomarkers for disease progression. 
rosophila models of AD have recently been developed and, due to their short lifespan and susceptibility to genetic manipulation, we have 
sed the fly to investigate the molecular connections among diet, aging and AD pathology. DR extended lifespan in both Arctic mutant A42 
nd WT 4R tau over-expressing flies, but the underlying molecular pathology was not altered and neuronal dysfunction was not prevented 
y dietary manipulation. Our data suggest that DR may alter aging through generalised mechanisms independent of the specific pathways 
nderlying AD pathogenesis in the fly, and hence that lifespan-extending manipulations may have varying effects on aging and functional 
eclines in aging-related diseases. Alternatively, our analysis of the specific effects of DR on neuronal toxicity downstream of A and tau 
athologies with negative results may simply confirm that the neuro-protective effects of DR are upstream of the initiating events involved in 
he pathogenesis of AD. 
 2009 Elsevier Inc. Open access under CC BY license.
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. IntroductionAlzheimer’s disease (AD) is a highly prevalent and devas-
ating aging-related condition. Clinically, AD patients display 
rogressive cognitive decline, including deficits in memory,
Abbreviations: DR, dietary restriction; AD, Alzheimer’s disease; A, 
myloid-beta; NFT, neurofibrillary tangle; APP, amyloid precursor protein; 
AD, familial Alzheimer’s disease; LOAD, late-onset Alzheimer’s disease; 
IS, insulin/IGF-like signalling; IF, intermittent fasting; AL, ad libitum; SY, 
ugar-yeast; WT, wild-type; UAS, upstream activator sequence; PI, perfor-
ance index; DT, decline time; GFS, giant fibre system; GF, giant fibre; 
TM, tergotrochanteral muscle; DLM, dorsal longitudinal flight muscle.
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unction and behaviour. AD is characterised pathologically 
y the presence of both extracellular amyloid-beta (A) 
laques and intraneuronal neurofibrillary tangles (NFTs), 
omposed of the microtubule-associated protein tau, which 
ccur mainly in regions of the brain involved in learning and 
emory. AD aetiology is multifactorial, with both genetic 
nd environmental factors implicated in its pathogenesis. 
amilial forms of the disease occur at an early age and are 
aused by autosomal dominant mutations in Presenilins 1 and 
 or the amyloid precursor protein (APP). More commonly, 
owever, AD occurs late in life (late-onset AD; LOAD) and 
he aetiological processes underlying this form of the disease 
re not well understood. Since aging is the most common 
isk factor for AD, it seems probable that molecular mech-
nisms underlying the aging process also play a role in the 
nitiation of AD pathogenesis. Some recent evidence from
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he study of model organisms suggests that this is indeed
he case. For instance, attenuation of insulin-like signalling
IIS) and dietary restriction both extend lifespan and protect
gainst A and, in the case of DR, against other types of
roteotoxicity in genetic models of disease in the nematode
orm Caenorhabditis elegans (Cohen et al., 2006; Steinkraus
t al., 2008). Investigation of the molecular mechanisms by
hich ameliorating the aging process can protect against AD
athology should highlight important pathways involved in
he initiation of sporadic AD pathogenesis, and hence lead to
he discovery of novel targets for disease-modifying therapies
nd biomarkers for the progression of the disease.
Dietary restriction (DR), a reduction in food intake that is
ot accompanied by malnutrition, extends lifespan in many
rganisms including the yeast Saccharomyces cerevisiae (Lin
t al., 2002), C. elegans (Klass, 1977; Houthoofd et al.,
003), the fruit fly Drosophila melanogaster (Chippindale
t al., 1993; Chapman and Partridge, 1996; Mair et al., 2003)
nd rodents (McCay et al., 1935; Masoro, 2005). DR has
lso been shown to delay several aging-related functional
eclines and disease processes (Bishop and Guarente, 2007;
air and Dillin, 2008). Many studies have reported benefi-
ial effects of DR on aging-associated cognitive defects in
odents (Pitsikas et al., 1990; Markowska and Savonenko,
002; Adams et al., 2008), although others have also reported
o positive effect (Bellush et al., 1996; Markowska, 1999;
itting et al., 2008) and the mechanism of protection, where
t occurs, remains to be established. Diets high in fat and
alories have been implicated as an important risk factor for
D (Luchsinger et al., 2002; Luchsinger and Mayeux, 2004).
oreover, dietary restriction has been shown to modify the
olecular neuropathology of the disease in animal models.
R confers protection against excitotoxic damage in mouse
eurons expressing a familial AD mutation in presenilin-1
Zhu et al., 1999), reduces A deposition (Patel et al., 2005;
ang et al., 2005; Halagappa et al., 2007), reduces tau hyper-
hosphorylation (Halagappa et al., 2007; Wu et al., 2008)
nd improves cognitive dysfunction in mouse models of AD
Halagappa et al., 2007). Importantly, different methods of
R have been shown to ameliorate cognitive decline in aged
ice displaying both A and tau pathologies (Halagappa et
l., 2007), but varying mechanisms have been proposed. DR
an be implemented in rodents by restricting the amount of
ood available for consumption to a fixed percentage of the
mount of standard laboratory diet eaten by the ad libitum
ed controls (Piper and Bartke, 2008), and is thought to assert
ts neuro-protective effects upstream of A and tau patholo-
ies by preventing their abnormal production (Halagappa et
l., 2007). Alternatively, intermittent fasting (IF), where ani-
als have no access to food for 24 h and ad libitum (AL)
ccess to food during the next 24 h (Piper and Bartke, 2008),
s thought to act downstream of AD pathogenesis (Halagappa
t al., 2007). The precise mechanisms mediating these effects,
owever, are unclear and whether there is a molecular connec-
ion between the effects of DR on aging and AD-associated
eclines in cognition remains to be established.
c
e
o
ding 32 (2011) 1977–1989
Most of our current understandings of the molecular deter-
inants of aging in response to DR have come from the
tudy of invertebrate model organisms such as yeast, worms
nd flies (Bishop and Guarente, 2007; Mair and Dillin,
008). Conserved regulators of DR longevity remain elu-
ive, but insulin-like signalling (IIS), target of rapamycin
TOR), AMP-dependent protein kinase (AMPK) and sirtuin
athways are candidate mechanisms for the regulation of DR-
ependent lifespan extension in multiple species (Bishop and
uarente, 2007; Mair and Dillin, 2008). Moreover, several
tudies have implicated components of the IIS and sirtuin
athways in mediating the neuro-protective effects of DR
n aging-related cognitive decline in rodents (Martin et al.,
006; Gillette-Guyonnet and Vellas, 2008).
D. melanogaster is a useful model organism in which to
urther study the complex interactions between DR, aging
nd AD due to its short lifespan, well-differentiated brain
nd susceptibility to genetic manipulation. Drosophila mod-
ls of Alzheimer’s disease have recently been developed
nd recapitulate separately many features of A and tau
athologies, including formation of amyloid plaques and neu-
ofibrillary tangles, neuronal death, behavioural impairment
nd shortened lifespan (Wittmann et al., 2001; Crowther et
l., 2005). Dietary restriction protocols are well established
n flies, most commonly implemented by diluting the con-
entration of nutrients in the fly food medium (Chapman
nd Partridge, 1996; Bass et al., 2007; Wong et al., 2008,
009), a method analogous to food restriction regimes used
n rodents. We have, therefore, examined the effects of DR
n lifespan and on biochemical and neuronal dysfunction
henotypes in flies over-expressing human A42 peptides
r 4R tau protein in the nervous system, with a view to
issecting the molecular mechanisms connecting DR, aging
nd AD.
Our study firstly extends the characterisation of fly AD
odels beyond previously published studies using electro-
hysiological methods to directly measure neuronal activity
n A42 and tau over-expressing flies. We propose that this
dditional measurement of synaptic activity, in combina-
ion with previously established behavioural phenotypes, will
rovide a better output response for the analysis of early
vents involved in the neuro-pathogenesis of AD in the fly.
ur findings also show that although DR extends lifespan,
t has no impact on A or tau pathologies in the nervous
ystem and it does not protect against neuronal dysfunc-
ion in these Drosophila models of AD. DR longevity may
issociate from the specific pathways underlying AD patho-
enesis that we examined, and supports the view that lifespan
nd aging-related pathology can be affected by different
echanisms. On the other hand, because our Drosophila
tudy specifically examines the effects of DR on events
ownstream of A and tau accumulation, our findings may
oncur with those in previous reports for mice (Halagappa
t al., 2007) that any protective effects of DR act upstream
f the initiating events in the pathogenesis of Alzheimer’s
isease.
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. Materials and methods
.1. Fly stocks and maintenance
All fly stocks were maintained and experiments conducted
t 25 ◦C on a 12:12-h light:dark cycle at constant humidity
sing standard sugar-yeast medium. Neuron-specific expres-
ion of Arctic mutant A42 peptide or WT 4R tau proteins
as achieved with the GAL4-UAS system [GAL4-dependant
pstream activator sequence (Brand and Perrimon, 1993)].
he A42 and tau UAS lines were obtained as generous
ifts: UAS-ArcA42 (Dr D. Crowther, Cambridge, UK)
nd UAS-WT 4R tau (Dr E. Skoulakis, Vari, Greece; origi-
ally sourced from Prof. M. Feany, Harvard Medical School,
SA). Elav GAL4C155 stocks were obtained from the Bloom-
ngton stock centre. All transgenes were backcrossed six
imes into the w1118 genetic background. Female flies car-
ying UAS-ArcA42 or UAS-WT 4R tau constructs were
rossed to male flies with the pan-neuronal GAL4 driver
lavGAL4C155 on the X chromosome. Female F1 progeny
arried both UAS and GAL4 constructs and were used for
ubsequent analyses.
.2. DR by yeast dilution series
Flies were raised at a standard density of 50 larvae
er vial on 1.0 sugar-yeast (SY) medium (15 g l−1 agar,
0 g l−1 sugar, 100 g l−1 autolysed yeast, 100 g −1 nipagin
nd 3 ml l−1 propionic acid). Two days after eclosion females
ere separated from males and transferred to experimental
ials, 10 flies per vial. Dietary restriction (DR) was imple-
ented with a constant sugar concentration (50 g l−1) and a
ariable yeast concentration (× Y; 0.1/10 g l−1, 0.5/50 g l−1,
.0/100 g l−1, 1.5/150 g −1 and 2.0/200 g −1). The yeast
ource was that referred to as SY Brewer’s in Bass et al.
2007).
.3. Lifespan analyses
Deaths were scored almost every day and flies were
ransferred to fresh food three times a week. Statistical com-
arisons of survival between genotypes were made using
og-rank tests at each food concentration, and within geno-
ypes between food concentrations to determine the food
ilution that maximised lifespan.
.4. Negative geotaxis assays
Negative geotaxis was analysed using 1.0 (DR) versus 2.0
fully fed) Y medium at various fly ages (1, 5, 10, 15, 25,
0 and 40 days old). Assays were performed according to
reviously published methods (Rival et al., 2004). Briefly, 15
dult flies were anaesthetised and placed in a vertical column
25 cm long, 1.5 cm diameter) with a conic bottom end and
llowed to recover from CO2 exposure for 30 min. For assays,
ies were tapped to the conic end of the column, then their
w
(
E
ting 32 (2011) 1977–1989 1979
limbing to the top of the column analysed. Flies reaching
he top of the column or remaining at the bottom after a 45 s
eriod were counted. Three trials were performed at 1 min
ntervals for each experiment. The mean number of flies at
he top (ntop), the mean number of flies at the bottom (nbottom)
nd the total number of flies assessed (ntot) were recorded.
Climbing ability was then analysed using several func-
ional descriptors as previously described (Martin et al.,
006): negative geotaxis data were calculated as a perfor-
ance index (PI) defined as 1/2(ntot + ntop − nbottom)/ntot.
T50 (time for function to decline to 50% of peak value) con-
tant was extrapolated from second-order polynomial curve
ts of the negative geotaxis data, and the total climbing
unction across ages was calculated as the area under the neg-
tive geotaxis curve for each group, using Prism 5.0 software
GraphPad software, San Diego, CA, USA).
.5. Electrophysiology
Recordings from the giant fibre system (GFS) of adult
ies were made as described in Allen et al. (1999); a method
ased on those described by Tanouye and Wyman (1980)
nd Gorcyzca and Hall (1984). Flies were anaesthetized by
ooling on ice and secured in wax, ventral side down, with
he wings held outwards. A tungsten earth wire (ground elec-
rode) was placed into the abdomen; tungsten electrodes were
ushed through the eyes and into the brain to deliver a 40 V
ulse for 0.03 ms using a Grass S48 stimulator. Record-
ngs were made from the tergotrochanteral muscle (TTM)
nd contralateral dorsal longitudinal muscle (DLM) using
lass microelectrodes (resistance: 40–60 M). The elec-
rodes were filled with 3 M KCl and placed into the muscles
hrough the cuticle. Responses were amplified using Getting
A amplifiers (Getting Instruments, USA) and the data digi-
ized using an analogue-digital Digidata 1320 and Axoscope
.0 software (Axon Instruments, USA). For response latency
ecordings, at least 5 single stimuli were given with 5 s rest
eriods between each stimulus; trains of 10 stimuli, at either
00, 200 or 250 Hz, were given with a 5 s rest interval between
ach train.
.6. Quantiﬁcation of total, soluble and aggregated
β42
To extract total A42, five fly heads were homogenised
n 50l GnHCl extraction buffer (5 M Guanidinium HCl,
0 mM Hepes pH 7.3, protease inhibitor cocktail (Sigma,
8340) and 5 mM EDTA), centrifuged at 21,000 × g for
min at 4 ◦C, and cleared supernatant retained as the total
y A42 sample. Alternatively, soluble and insoluble pools
f A42 were extracted using a protocol adapted from previ-
usly published methods (Burns et al., 2003): 200 fly heads
ere homogenised in 200l tissue homogenisation buffer
250 mM sucrose, 20 mM Tris base, 1 mM EDTA, 1 mM
GTA, protease inhibitor cocktail (Sigma)) then mixed fur-
her with 200l DEA buffer (0.4% DEA, 100 mM NaCl
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nd protease inhibitor cocktail). Samples were centrifuged
t 135,000 × g for 1 h at 4 ◦C (Beckman OptimaTM Max
entrifuge, TLA120.1 rotor), and supernatant retained as
he cytosolic, soluble A42 fraction. Pellets were further
esuspended in 400l ice-cold formic acid (70%), and son-
cated for 2× 30 s on ice. Samples were re-centrifuged at
35,000 × g for 1 h at 4 ◦C, then 210l of supernatant diluted
ith 4 ml FA neutralisation buffer (1 M Tris base, 0.5 M
a2HPO4, 0.05% NaN3) and retained as the aggregated,
ormic acid-extractable A42 fraction.
Total, soluble or aggregated A42 content was measured
n Arctic mutant A42 flies and controls using the hAmyloid-
42 ELISA kit (HS) (The Genetics Company, Switzerland).
otal and soluble A42 samples were diluted 1:10, and aggre-
ated A42 samples diluted 1:5 in sample/standard dilution
uffer and the ELISA performed according to the manufac-
urers’ instructions. Protein extracts were quantified using
he Bradford protein assay (Bio-Rad protein assay reagent;
io-Rad laboratories Ltd. (UK)) and the amount of A42 in
ach sample expressed as a ratio of the total protein content
pmol/g total protein).
.7. Analysis of tau phosphorylation by western blotting
Tau phosphorylation was analysed in WT 4Rtau over-
xpressing flies and controls by western blotting. 20
rosophila heads were homogenised in 2× Laemmli sam-
le buffer containing -mercaptoethanol and boiled for
min. Proteins were separated on 10% sodium dodecyl
ulfate–polyacrylamide (SDS–PAGE) gels at 150 V for 1 h.
els were then transferred to nitrocellulose membranes,
ncubated in a blocking solution containing 5% milk pro-
eins in TBST for 1 h at room temperature, then probed
ith primary antibodies overnight at 4 ◦C. The primary
ntibodies used were: anti-tau polyclonal antibody (DAKO,
K) is phosphorylation independent and recognises all tau
soforms, monoclonal antibody PHF-1 recognises tau phos-
horylated at epitope Ser396/404 and was kindly provided
y Dr P. Davies (Albert Einstein College of Medicine, NY,
SA), monoclonal antibody AT8 (Innogenetics) recognises
au phosphorylated at the Ser199/202 epitope, polyclonal
ntibodies pS422 and actin (Abcam, UK) recognise the
er422 phospho-epitope of tau and total actin proteins
espectively. Anti-horseradish peroxidase (HRP)-conjugated
econdary antibodies were used and blots were developed
sing the enhanced chemiluminescence method (ECL; Amer-
ham Biosciences). The relative tau immunoreactivity for
ach antibody was analysed using Image J software (National
nstitutes of Health). Absolute intensity of phosphorylated
au was normalised to the total tau protein present in each
ample (relative intensity)..8. Statistical analyses
Data are presented as means ± SEM obtained in at least
hree independent experiments. Log-rank tests, analysis of
o
h
c
Aing 32 (2011) 1977–1989
ariances and Tukey’s HSD (honestly significant difference)
ost-hoc analyses were performed using JMP (version 7.0)
oftware (SAS Institute, Cary, NC, USA).
. Results
.1. Dietary restriction extends lifespan in Drosophila
odels of Alzheimer’s disease
Over-expression of human Arctic A42 and wild-
ype tau proteins was confirmed in flies heterozygous
or both elav GAL4 and the UAS-ArcA42 (w1118elav/+;
AS-ArcA42/+) or UAS-WT4Rtau (w1118elav/+;UAS-
T4Rtau/+) transgenes respectively, compared to control
ies expressing elav GAL4 (w1118elav/+) or UAS-ArcA42
w1118;UAS-ArcA42/+) or UAS-WT4Rtau (w1118;UAS-
T4Rtau/+) alone (Fig. 1A and B). Consistent with
reviously published studies (Crowther et al., 2005), Arctic
42 over-expressing flies showed substantially shortened
ifespan compared to the elav GAL4 and UAS-ArcA42
ransgene controls (Fig. 1C). In contrast, WT 4R tau over-
xpressing flies did not differ in lifespan from the UAS-WT
R tau transgene control (Fig. 1D), although survival of both
f these lines was substantially reduced in comparison to
he elav GAL4 driver line. Western blotting of whole fly
eads revealed that the UAS-WT 4R tau transgene was leaky
Fig. 1B). Leaky expression of tau in tissues other than neu-
ons may therefore account for the reduction in lifespan of
oth the UAS-control line and the tau over-expressing flies
ompared to the GAL4 line alone. Alternatively, the level of
eaky expression in the nervous system itself may have been
ufficient to reduce lifespan in the UAS-control line.
DR can be achieved in flies by dilution of the nutrients
n their food medium (Chapman and Partridge, 1996). As
ood concentration declines from a maximum, lifespan first
ncreases to a maximum in response to DR, before declin-
ng due to starvation at lower food concentrations. However,
he particular diet that maximises lifespan can vary across
ifferent Drosophila strains, and so was empirically deter-
ined for each of the lines used in the current study using a
ange of food concentrations in which the yeast component
as diluted to 0.1, 0.5, 1.0, 1.5 and 2.0× yeast (Y) compared
o the standard SY medium (Fig. 2A and B). Although the
R peaks were broad in some cases (Table 1; see footnotes
, ‡), dietary responses for all genotypes were: starvation at
.1 Y, DR at 0.5 to 1.5 Y and fully fed at 2.0 Y (Fig. 2 A
nd B, and Table 1). Arctic A42 and tau reduced lifespan
henotypes were not apparent on 0.1 Y medium (Fig. 2A
nd B) compared to the elav GAL4 control line, presum-
bly because all genotypes were starved, resulting in death
rior to the onset of mortality caused by the over-expression
f A42 or tau proteins. Over-expression of Arctic A42,
owever, did shorten lifespan compared to UAS and GAL4
ontrols on all other food concentrations studied (Fig. 2A).
reduction in food concentration from the fully fed con-
F. Kerr et al. / Neurobiology of Aging 32 (2011) 1977–1989 1981
Fig. 1. Biochemical confirmation of protein over-expression in Arctic A42 and WT 4Rtau female flies. Flies were reared and maintained on 1.0 SY medium,
then protein content quantified at 15 days old. (A) Detection of A42 peptides in w1118elav/+;UAS-ArcA42/+ and control (w1118elav/+, w1118w1118;UAS-
ArcA42/+) flies by sandwich ELISA (the Genetics Company; see Section 2). Data are presented as means ± SEM. P < 0.05 comparing w1118w1118elav/+;UAS-
A tau in 1118 1118 1118
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trcA42/+ to both controls (Tukey’s HSD). (B) Analysis of WT human 4R
Rtau/+) flies by western blotting using a non-phosphorylation-dependent a
Y medium for flies over-expressing (C) Arctic A42 peptides or (D) WT 4
ition increased the lifespan of Arctic A42 flies, but this
as insufficient to rescue survival back to the level of control
ies, and the lifespan curves for the experimental and control
enotypes remained roughly parallel throughout the DR food
ilution range (Fig. 2A). DR thus neither rescued nor ame-
iorated the reduction in lifespan caused by A pathology in
his Drosophila model. On the other hand, despite the lack
f a neuronal-specific effect of tau on lifespan at all yeast
oncentrations, nutritional dilution did improve the survival
f both tau transgenic lines (w1118elav/+;UAS-WT4Rtau/+,
1118;UAS-WT4Rtau/+), and completely rescued the effect
o
m
p
ig. 2. Median lifespans of flies over-expressing Arctic A42 peptides or WT hu
1118elav/+;UAS-ArcA42/+ or (B) w1118elav/+;UAS-4Rtau/+ and their control
erformed across a yeast dilution series (0.5S, variable Y; see Section 2). Flies wer
istributed onto the appropriate 0.1, 0.5, 1.0, 1.5, 2.0× Y medium. Lifespans were
roup across the yeast dilution series are plotted. *P < 0.01, ***P < 0.000001 compar
o that of both control groups (log-rank tests). w1118elav/+ flies were the same for bw elav/+;UAS-WT 4Rtau/+ and control (w elav/+, w ;UAS-WT
ntibody (Dako; see Section 2). Lifespans were determined on standard 1.0
mpared to their GAL4 and UAS controls, and survival curves are depicted.
f leaky tau expression on reduced longevity compared to
lav GAL4 controls at the 0.5 Y concentration (Fig. 2B and
able 1). Hence, DR does appear to protect against the toxic
ffect of tau on lifespan but the effect could be mediated
n tissues other than the nervous system, since the rescue is
imilar for w1118elav/+;UAS-WT4Rtau/+ and w1118;UAS-
T4Rtau/+ flies.f DR under our experimental conditions in these Drosophila
odels of AD, but point to mechanisms that may be uncou-
led from the neuron-specific defects.
man 4R tau across a yeast dilution series on SY food. Lifespans of (A)
(w1118elav/+, w1118;+/UAS-ArcA42, w1118;+/UAS-4Rtau) females were
e reared at a standard density on 1.0 SY, and at day 3 mated females were
determined (as described in Section 2) and median lifespan values for each
ing survival of w1118elav/+;UAS-ArcA42/+ or w1118elav/+;UAS-4Rtau/+
oth A42 and tau experiments which were run in parallel.
1982 F. Kerr et al. / Neurobiology of Aging 32 (2011) 1977–1989
Table 1
Median lifespan and statistical analysis of Arctic Ab42 and WT 4Rtau overexpressing female flies across a yeast dilution series on SY food.
Survival analysis of Arctic A42 and WT 4R tau over-expressing flies; median lifespan values (m), number of flies per group (n) and P values are indicated. *P
values calculated using log-rank tests comparing w1118elav/+;UAS-ArcA42/+ or w1118elav/+;UAS-4Rtau/+ flies with the relevant GAL4 and UAS controls
on the same food dilution. Bold P values indicate that flies were longer lived than control flies; †Yeast dilution-range at which peak median lifespan was
observed for each genotype. ‡P values of log-rank tests comparing flies across the yeast-dilution series for each genotype, significant values are depicted in
red (P < 0.01). w1118elav/+ flies were the same for both A42 and tau experiments which were run in parallel.
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T.2. Dietary manipulation does not alter the abnormal
ccumulation of Aβ42 peptides or tau in Drosophila
Since lifespan peaked between 0.5 and 1.5 Y and all geno-
ypes showed reduced lifespan on 2.0 Y medium, further
nalyses of the effects of diet on AD pathology were per-
ormed using 1.0 Y as ‘DR’ food and 2.0 Y as ‘fully fed’
ood. As a measure of early changes in the molecular pathol-
gy of AD in response to diet, A42 accumulation and tau
hosphorylation levels were assessed in Arctic A42 and WT
R tau over-expressing flies, respectively, across age on DR
ersus fully fed dietary regimen (Figs. 3 and 4).
w1118elav/+;UAS-ArcA42/+ flies did not express
etectable levels of total (soluble and insoluble) A42 pep-
ides upon eclosion, but A42 accumulated to detectable
evels at 15 days old peaked at 30 days old (Fig. 3A).
ietary manipulation did not affect either the time-course
r expression of A42 peptide (Fig. 3A; grey vs black bars).
42 transcript levels were also unaltered by changes in diet
t
(
hFig. S1A). Soluble and aggregated A42 levels were fur-
her assessed in 15 days old w1118elav/+;UAS-ArcA42/+
ies. At this time-point most A42 was distributed in the
nsoluble, formic acid-extractable pool with very little sol-
ble A42 present (Fig. 3B; grey vs black bars); consistent
ith the known effect of the Arctic mutation to enhance A
ggregation (Nilsberth et al., 2001; Philipson et al., 2008) and
revious reports of A42 distribution in Drosophila models
Finelli et al., 2004; Iijima et al., 2004). DR also had no sig-
ificant effect on this pattern of A aggregation (Fig. 3B; 1.0
s 2.0 Y food). GAL4 and UAS control flies did not express
oluble or insoluble A42 peptides (Fig. 3).
w1118elav/+;UAS-WT4Rtau/+ flies expressed detectable
evels of tau protein upon eclosion and this level of expres-
ion was maintained throughout life (Fig. 4; anti-tau).
au phosphorylation, as assessed at three independent epi-opes using phosphorylation-dependent antibodies [PHF-1
Ser396/404); AT8 (Ser199/202); pS422 (Ser422)], was also
igh upon eclosion in these flies and the degree of phos-
F. Kerr et al. / Neurobiology of Ag
Fig. 3. Biochemical analysis of fully fed vs DR food effects on A42
levels and aggregation in flies over-expressing Arctic mutant A42. (A)
Dietary manipulation effects on A42 accumulation in w1118elav/+;UAS-
ArcA42/+ female flies across age. Flies were aged on the appropriate 1.0
or 2.0 Y medium and total A42 levels measured by ELISA at the indicated
timepoints. Data are presented as the mean ± SEM of the A42 concen-
tration in pmol/g total protein. Dietary effects on total A42 levels across
age in w1118elav/+;UAS-ArcA42/+ flies were analysed using a two-way
ANOVA (n = 3). P = 0.267 comparing w1118elav/+;UAS-ArcA42/+ on 1.0
Y to that of flies on 2.0 Y, P = 0.0001 comparing A42 levels across age.
Tukey’s HSD analysis revealed significant differences in A42 levels in flies
aged for 30 or 40 days compared to those at 1, 5 and 15 days old (P < 0.05).
(B) Dietary manipulation effects on A42 aggregation in w1118elav/+;UAS-
ArcA42/+ female flies. Soluble and aggregated (formic acid-extractable)
A42 levels were measured by ELISA following 15 days treatment on the
DR regime. Data are presented as means ± SEM. Dietary effects on each
pool of A42 in w1118elav/+;UAS-ArcA42/+ flies were analysed by two-
way ANOVA (n = 3; P < 0.0001, comparing soluble vs aggregated A42;
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r= 0.057, comparing A42 on 1.0 vs 2.0 Y medium).
horylation was unaltered with age. The level and pattern of
au expression and phosphorylation was identical between
R and fully fed conditions at all time-points (Fig. 4; 1.0 vs
.0 Y). Tau transcript levels were also unaltered by dietary
anipulation (Fig. S1B).
Alterations in diet, therefore, do not regulate the accu-
ulation of A42 or tau or the phosphorylation status of
au in these Drosophila models of AD. Hence, the protec-
ive effects of DR on tau-induced lifespan reduction do not
ppear to be mediated by alterations in tau expression or
hosphorylation.
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.3. DR does not alter negative geotaxis
Since DR does not prevent the abnormal accumulation
f A42 peptides or tau, and does not appear to alter
euronal-specific lifespan-shortening effects in the fly, we
ext investigated the effects of diet on neuronal function
ownstream of these pathologies. As a behavioural measure
f neuronal dysfunction in our Drosophila models of AD,
ocomotor activity was assessed using a negative geotaxis
climbing) assay that has been used previously to char-
cterise several fly models of neurodegenerative disease,
ncluding Parkinson’s disease (Feany and Bender, 2000) and
lzheimer’s disease (Mudher et al., 2004; Crowther et al.,
005).
Drosophila display an aging-related decline in climbing
Martin and Grotewiel, 2006) and this was apparent in the
ontrol flies used in the current study (Fig. 5). Arctic mutant
42 over-expressing flies, however, displayed reduced neg-
tive geotaxis (Fig. 5A) and an earlier onset of decline
Fig. 5C; DT50) and total function across age (Fig. 5E)
ompared to both GAL4 and UAS control flies. Similarly,
au over-expressing flies showed a reduced negative geotaxis
Fig. 5B) and total function across age (Fig. 5F), but the time
o decline (Fig. 5D) was not significantly different compared
o control flies. Unlike the 4R tau effects on lifespan, however,
his tau-induced impairment of climbing ability is a neuronal-
pecific phenotype, since w1118elav/+;UAS-WT4Rtau/+ flies
isplayed reduced negative geotaxis compared to both the
AS and GAL4 controls.
DR had no significant effect on the impairment of nega-
ive geotaxis. A similar negative geotaxis (Fig. 5 A and B),
ecline time (Fig. 5C and D) and total function (Fig. 5E
nd F) was observed on 1.0 versus 2.0 Y medium for all
enotypes. Hence, dietary manipulation does not alter either
he neuronal-specific impairment of negative geotaxis caused
y the accumulation of toxic A42 peptides or phospho-
ylated tau protein, or the aging-related decline in negative
eotaxis observed in control flies. Our data, therefore, agree
ith previously published studies demonstrating dissociation
etween the effects of DR on lifespan and functional senes-
ence in the fly (Bhandari et al., 2007; Burger et al., 2007),
nd show further that these observations may also extend to
ging-related disease processes.
.4. DR does not prevent neuronal dysfunction in ﬂies
ver-expressing Arctic Aβ42 or tau protein
Previously published studies have used behavioural
efects, such as reductions in negative geotaxis and olfactory
onditioning, as indicative measures of neuronal dysfunction
n Drosophila models of AD, and end-stage measures of neu-
onal death, such as neuronal loss and apoptosis, to directly
haracterise neuronal abnormalities (Wittmann et al., 2001;
ijima et al., 2004; Crowther et al., 2005). Direct measures of
euronal activity in these flies have not been reported, how-
ver, and may better facilitate the analysis of early stages
1984 F. Kerr et al. / Neurobiology of Aging 32 (2011) 1977–1989
Fig. 4. Analysis of fully fed vs DR food effects on tau levels and phosphorylation in flies over-expressing WT human tau. (A) Tau expression and phosphorylation
levels were measured by western blotting in control flies (w1118elav/+, w1118;UAS-4Rtau/+), and at the indicated timepoints in w1118elav/+;UAS-4Rtau/+ flies
treated on 1.0 vs 2.0 Y medium. Primary antibodies were as follows: Anti-tau (total tau; Dako, UK), PHF-1 (phospho-Ser396/404 tau), AT8 (phospho-Ser199/202
tau), pS422 (phospho-Ser422 tau) and anti-actin. (B) Phospho-tau levels, in w1118elav/+;UAS-4Rtau/+ flies, were normalised to total tau protein for each sample,
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pnd are expressed as average relative intensities ± SEM. Dietary manipulatio
P = 0.412), Ser199/202 (P = 0.838) or Ser422 (P = 0.677) epitopes (two-wa
f AD-related neuronal toxicity in Drosophila. Hence, we
xamined the effects of expression of Arctic A42 or tau
roteins and of diet on electrophysiological responses of the
ervous system in adult flies.
The giant fibre system (GFS), which mediates jump-and-
ight escape responses, is a useful system for measuring
euronal function, due to its well-defined, easily accessible
entral nervous system circuitry (Allen et al., 2006). It has
een used previously to characterise neuronal dysfunction in
y models of neurodegenerative diseases, such as amyotropic
ateral sclerosis (ALS) (Watson et al., 2008). Giant fibres (GF)
re interneurons that relay signals from the brain to two main
lectrochemical synapses in the thoracic ganglion of the fly;
ne to the motorneuron (TTMn) of the tergotrochanteral mus-
le (TTM) and the other to the motorneurons (DLMns) of the
orsal longitudinal flight muscle (DLM) via the peripherally
ynapsing interneuron (PSI) [Fig. 6A (Allen et al., 2006)].
FS activity was determined in our study by stimulating the
iant fibres via electrodes inserted inside the compound eye
b
fl
rot alter the level or pattern of tau phosphorylation across age at Ser396/404
VA).
nd recording post-synaptic potentials in the TTM and DLM;
arameters measured were the latencies from GF stimulation
o muscle response and the stability of the response to high
requency stimulation.
We measured GFS activity in flies over-expressing Arc-
ic A42 or tau proteins on 1.0 and 2.0 Y food at 7 days
ld, an age at which the deficiency in climbing ability was
ild (Fig. 5A and B) and therefore neuronal dysfunction
ore likely to be modifiable by dietary manipulation. Expres-
ion of Arctic A42 peptides significantly increased the
esponse latency measured in the TTM, and inhibited the
tability of the TTM response to high frequency stimulation
at 200 and 250 Hz) in comparison to elav GAL4 controls,
ndicating a defective response of the TTM to GF stimu-
ation (Fig. 6B and Fig. S2). In flies over-expressing tau
roteins the response latency in the TTM was compara-
le between w1118elav/+;UAS-WT4Rtau/+ and w1118elav/+
ies, but the response to high frequency stimulation was
educed at 200 and 250 Hz (Fig. 6C and Fig. S2). This indi-
F. Kerr et al. / Neurobiology of Aging 32 (2011) 1977–1989 1985
Fig. 5. Negative geotaxis behaviour of flies over-expressing Arctic A42 peptides or WT 4R tau on fully fed vs DR SY food. Climbing ability of
w1118elav/+;UAS-ArcA42/+, w1118elav/+;UAS-WT4Rtau/+ and control (w1118elav/+, w1118;UAS-ArcA42/+, w1118;UAS-WT4Rtau/+) flies on 1.0 vs 2.0
Y medium was assessed across age using several functional descriptors (see Section 2). Data are presented as means ± SEM and were compared using two-way
ANOVA and Tukey’s honestly significant difference (HSD) post hoc analyses (number of independent tests (n) = 3, number of flies per group (nt) = 43–45).
(A and B) Negative geotaxis. Data are expressed as the average performance index (PI) ± SEM for each genotype across age. *P < 0.05 comparing PI of
w1118elav/+;UAS-ArcA42/+ or w1118elav/+;UAS-WT4Rtau/+ to that of both GAL4 and UAS control groups at the indicated timepoints (Tukey’s HSD). For
all genotypes, no significant effect of food on negative geotaxis was observed by two-way ANOVA (P = 0.491). (C and D) Decline time (DT). DT50 (time for
function to decline to 50% of peak value) constants were interpolated from second-order polynomial curve fits, using the data presented in (A) and (B), for each
group. Data are presented as DT ± SEM. †P < 0.05 comparing DT50 of w1118elav/+;UAS-ArcA42/+ to that of both control groups (Tukey’s HSD). For all
genotypes, no significant difference was observed comparing DT50 values on 1.0 vs 2.0 Y medium (P = 0.8971, two-way ANOVA). (E and F) Total negative
geotaxis was determined as the area under the curve for each group presented in (A) and (B). Data are shown as total function ± SEM. *P < 0.05 comparing
w1118elav/+;UAS-ArcA42/+ or w1118elav/+;UAS-WT4Rtau/+ to that of GAL4 and UAS control groups (Tukey’s HSD). For all genotypes no significant
d vs 2.0 Y
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sifference in total function was observed comparing flies maintained on 1.0
or both A42 and tau experiments which were run in parallel.
ates a relatively mild tau-induced dysfunction in the GFS
t this time-point, whereby TTM responses exhibit a nor-
al latency to a single stimulus, but synaptic deficits are
pparent when the GFS is challenged with stronger high
requency stimuli. DLM response latencies, however, were
naffected by over-expression of Arctic A42 (Fig. S3A)
r WT tau (Fig. S3B), suggesting that the neuronal defects
bserved may be specific to the GF-TTMn synapse. Dietary
anipulation did not alter this pattern of neuronal dysfunc-
r
fl
omedium (P = 0.4692, two-way ANOVA). w1118elav/+ flies were the same
ion, since response latencies and the stability of responses
o high frequency stimulation did not differ on 1.0 and 2.0
media both for flies over-expressing Arctic A42 (Fig. 6B
nd Fig. S2) or tau (Fig. 6C and Fig. S2) in the nervous
ystem.
Our results clearly show that diet does not modulate neu-
onal toxicity downstream of A42 or tau pathologies in the
y, when measured either indirectly by behavioural analysis
r directly by testing neuronal activity.
1986 F. Kerr et al. / Neurobiology of Aging 32 (2011) 1977–1989
Fig. 6. Neuronal electrophysiology of flies over-expressing Arctic A42 peptides or WT 4R tau on fully fed vs DR SY food. (A) A schematic illustration of the
Drosophila giant fibre system (GFS (Allen et al., 2006) reproduced with permission from Elsevier). Giant fibres (GF; red) relay signals from the brain to the
thoracic musculature via mixed electrochemical synapses with the motorneurons (TTMn, blue) of the tergotrancheral muscle (TTM; left), and the peripherally
synapsing interneuron (PSI; green) which subsequently forms chemical synapses with the motorneurons (DLMn; yellow) of the dorsal longitudinal muscles
(DLM; right). Note only one of the TTMn axons is shown exiting the central nervous system and contacting the muscle on the left hand side and one set of
the DLMns and corresponding neuromuscular junctions are depicted on the right hand side. GFS activity was measured, in flies over-expressing (B) A42
peptides or (C) tau protein on fully fed and DR dietary conditions compared to GAL4 controls, by stimulating the giant fibres via electrodes inserted inside the
compound eye and recording post-synaptic potentials in the TTM; parameters measured were the latencies from GF stimulation to muscle response (response
latency TTM) and the stability of the response to high frequency stimulation at 100, 200 and 250 Hz (high frequency stimulation TTM). Data are presented as
means ± SEM. Analysis was performed by one-way ANOVA and Tukey’s HSD post hoc comparisons on log-derived data (n = 6-9 for all groups). *P < 0.05
comparing responses of w1118elav/+;UAS-ArcA42/+ or w1118elav/+;UAS-WT4Rtau/+ flies on 1.0 or 2.0 Y medium to that of elav GAL4 controls (Tukey’s
HSD). No significant differences were observed comparing either w1118elav/+;UAS-ArcA42/+ or w1118elav/+;UAS-WT4Rtau/+ flies on 1.0 Y to those on 2.0
Y nalysis
d nd, the
4
o
b
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a
imedium. Data were not normally distributed at 100 Hz stimulation, but a
ifferences. (For interpretation of the references to colour in this figure lege
. Discussion
D. melanogaster has proven to be a valuable model
rganism for studying the molecular mechanisms involved
oth in the aging process (Bishop and Guarente, 2007)
nd in various neurodegenerative diseases (Bilen and
l
c
Ausing the non-parametric Kruskal–Wallis ANOVA revealed no significant
reader is referred to the web version of the article.)
onini, 2005). To explore the connections between the
ging process and neurodegenerative disease, we exam-
ned the effects of dietary restriction, which extends
ifespan in wild-type flies, on lifespan and biochemi-
al and neuronal dysfunction in Drosophila models of
D.
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AF. Kerr et al. / Neurobiolog
Our study extended the characterisation of fly AD mod-
ls by introducing a direct measure of neuronal activity in
esponse to A42 or tau over-expression in the Drosophila
ervous system. Other studies have analysed defects in axonal
ransport in Drosophila larvae as a direct measure of neu-
onal function in flies over-expressing APP (Gunawardena
nd Goldstein, 2001) or tau proteins (Mudher et al., 2004).
hese defects may represent abnormal neuronal develop-
ent in addition to any neurodegeneration in response to
D pathology. We, therefore, developed a direct measure of
euronal dysfunction in adult flies over-expressing A42 or
au proteins, by analysing the electrophysiological responses
f the giant fibre system. Pan-neuronal over-expression of
42 or tau proteins resulted in reduced responsiveness
f the GFS pathway, compared to both elav GAL4 and
AS controls. There are thus specific defects in neuronal
unction in the motor system of flies over-expressing these
roteins. We propose that this more direct measurement
f neuronal dysfunction, in combination with previously
stablished behavioural assays, will better facilitate the inves-
igation of the mechanisms regulating early stages of AD
athogenesis.
Dietary restriction extended the lifespan of both flies
ver-expressing A42 or tau in the nervous system and of
ontrols. DR thus slowed aging in all the fly genotypes in
he study. However, the magnitude of the extension of lifes-
an by DR was similar in the flies over-expressing A42 and
heir controls, suggesting that slowing the aging process did
ot ameliorate the reduction in lifespan induced by A42
xpression. Consistent with this observation, dietary manip-
lation did not alter the abnormal accumulation of A42,
ith equivalent levels of aggregated A42 peptides present
nder DR and fully fed dietary conditions. On the other
and, tau-induced lifespan-shortening effects, observed both
n elav;UAS-WT4Rtau and +;UAS-WT4Rtau flies compared
o elav GAL4 controls, were completely reversed by DR.
his could suggest that DR ameliorated the negative effect
n lifespan of tau over-expression in neurons. However, an
lternative and more likely explanation is that DR rescued the
ffects of leaky over-expression of tau in tissues other than the
ervous system, since both the reduction in lifespan and its
melioration by DR were similar in the tau over-expressing
ies and the +;UAS-WT4Rtau controls. In support of this
nterpretation, DR did not alter tau expression or phospho-
ylation. Neuronal dysfunction downstream of A42 or tau
as not prevented by our dietary restriction protocol. We
sed both direct (electrophysiology) and indirect (negative
eotaxis) measures of neuronal function, and although both
ere compromised by A42 and tau over-expression, DR did
ot ameliorate the effects.
Our data thus imply that DR protected against proteotoxic
henotypes in non-neuronal tissues (tau-induced lifespan
hortening), but not against neuron-specific abnormalities
A42-induced lifespan shortening; A42 or tau-induced
limbing and neuronal activity defects) in response to AD
athologies. Consistent with these findings, DR has been
f
c
m
eing 32 (2011) 1977–1989 1987
hown to protect against A42 toxicity in worms over-
xpressing the peptide in non-neuronal tissues (Steinkraus et
l., 2008). Our study, therefore, highlights the likely impor-
ance of studying the nervous system specifically when trying
o understand the mechanisms involved in the pathogenesis
f AD and other neurodegenerative diseases using in vivo
odels.
An important finding of our study is that the processes
egulating mortality and neurodegeneration can be uncou-
led, since DR extended lifespan without ameliorating the
oxicity associated with these two Drosophila models of AD.
onsistent with this observation, flies expressing a mutation
n the ADAR (Adenosine Deaminase Acting on RNA) gene
isplay severe, progressive neuro-behavioural impairments,
ut are not short-lived (Palladino et al., 2000). Moreover,
lthough many studies have suggested that dietary restriction
ay have neuro-protective properties in rodents (Gillette-
uyonnet and Vellas, 2008), various studies have reported
o effect (Bellush et al., 1996; Markowska, 1999; Fitting
t al., 2008), a positive effect (Pitsikas et al., 1990; Eckles-
mith et al., 2000; Markowska and Savonenko, 2002), or
ven a negative effect (Yanai et al., 2004) of DR on aging-
ssociated cognitive decline in these models. Several recent
tudies have also revealed a complex relationship between the
ffects of dietary restriction on demographic aging and aging-
elated functional declines in Drosophila (Bhandari et al.,
007; Burger et al., 2007). DR has consistently been shown
o extend lifespan in flies (Bhandari et al., 2007; Burger et al.,
007; Grandison et al., 2009), but has also been reported to
ause age-dependent reductions in stress resistance (Burger
t al., 2007) and no effect on negative geotaxis or olfactory
ehaviour (Bhandari et al., 2007). This has led to the sugges-
ion that the mechanisms underlying DR-mediated effects on
ifespan and aging-related declines in function may dissoci-
te. Our results support these findings since we have observed
o effect of DR on the aging-related senescence of negative
eotaxis in control flies, and DR also did not ameliorate the
euronal-regulated decline in climbing ability caused by the
ver-expression of A42 or tau proteins in the Drosophila
ervous system.
Our findings apparently conflict with previously published
tudies demonstrating that dietary restriction can improve
ognitive function (Halagappa et al., 2007; Wu et al., 2008),
revent amyloid accumulation (Patel et al., 2005; Wang et
l., 2005; Halagappa et al., 2007) and reduce tau phospho-
ylation (Halagappa et al., 2007; Wu et al., 2008) in mouse
odels of AD. This discrepancy could indicate that the mech-
nisms underlying the effects of DR on aging differ between
rganisms (Piper and Partridge, 2007). Alternatively, since
R and intermittent fasting (IF) are hypothesised to medi-
te their neuro-protective effects at distinct stages of the
D pathological process (Halagappa et al., 2007), the dif-erence may be explained by variations in the particular
ombination of DR protocol and AD process modelled in the
ouse and Drosophila studies. Most studies examining the
ffects of DR on AD pathology have been performed using
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ice which over-express familial AD mutations in human
PP (Wang et al., 2005; Halagappa et al., 2007), or mutant
orms of tau in combination with APP and/or presenilin-
to induce hyperphosphorylation (Halagappa et al., 2007;
u et al., 2008). Hence processes both upstream and down-
tream of A production and tau hyperphosphorylation can
e examined in these models. Intermittent fasting, despite
meliorating cognitive decline, has no effect on A levels or
au phosphorylation in mice, leading to the hypothesis that
he neuro-protective effects of IF act downstream of these
athologies in AD (Halagappa et al., 2007). Conversely, DR
educes A levels (Patel et al., 2005; Wang et al., 2005;
alagappa et al., 2007), possibly by increasing activity of the
on-amyloidogenic APP cleaving enzyme -secretase (Qin
t al., 2006), prevents tau hyperphosphorylation (Halagappa
t al., 2007; Wu et al., 2008), possibly by reducing activity of
he tau kinase cyclin dependent kinase-5 (CDK-5) (Wu et al.,
008), and prevents cognitive decline in these models, sug-
esting that DR exerts a neuro-protective effect upstream of
 and tau pathogenesis. The Drosophila models used in our
tudy, however, express A42 peptides or tau in the absence
f any confounding factors upstream of their production,
yperphosphorylation or accumulation, and so enable a more
efinitive analysis of the processes occurring directly down-
tream of these pathologies in AD. As our dietary restriction
rotocol most resembles the DR regime used in mice, the
bsence of neuro-protective effects of DR in our fly models
ay confirm that any protective effects of DR on AD act
rmly upstream of the production of A and tau pathologies.
Overall our findings show overwhelmingly that DR-
ediated effects on lifespan and neuronal declines in
rosophila may dissociate, and demonstrate that this dis-
ociation particularly applies to Alzheimer’s disease-related
rocesses following the initiation of A and tau pathologies.
oreover, our study provides strong support for the hypoth-
sis that the neuro-protective effects of dietary restriction
egimes act upstream of A and tau pathogenesis in AD.
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